G4A: Growth Track

 

Deadline: June 20th, 2021

The Growth Track is our offer for early to mid-stage startups. This track is a good fit for Seed and Series A startups with a minimal viable product validated through patents and publications. And of course, a stellar and diverse team! Our Growth Track startups benefit from coaching and executive mentorship as well as funding.

Current Challenges

  • Lifestyle Behavior Change, Cardiometabolic and Renal Diseases

  • Patient Monitoring and Digital Biomarkers, Cardiometabolic and Renal Diseases

  • Social Support, Cardiometabolic and Renal Diseases

  • Screening/Diagnosis and Improvement of Bone Health, Women’s Health Care

  • Screening and Diagnosis of PCOS and Endometriosis, Women’s Health Care

  • Mental Health and Mindfulness, Mental Health

More information: Growth Track Partnership | Digital Health Startups | G4A

 

 

Bayer G4A invests this year again in Digital Health Start-Ups. The application period is only open until June 20, 2021!

Companies with digital health solutions can still apply for this year's Bayer G4A "Digital Health Partnerships Program" until June 20, 2021. G4A offers an acceleration program with investments between €25,000 and €100,000 and mentoring. Digital health companies that have been in the market for a longer period of time and have a mature solution can apply to the "Advance Track" program and have the opportunity to benefit from long-term partnerships with Bayer Pharmaceuticals.

Bayer G4A aims to drive digital health solutions that solve some of the most pressing health challenges and are more closely aligned with patient needs. This year, the Health Challenges aim to find and promote digital innovations in cardiology, oncology, women's health, mental health and radiology. 

For more information on the Challenges and to apply for the G4A Partnerships Program, visit the Bayer G4A website: https://www.g4a.health/  

Back